REDUCED 1 - Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study /

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a prospective, multicenter, non-randomized, open-label clinical study of the safety and performance of the TIVUS™ System in subjects with uncontrolled stage 2 hypertension in order to assess the safety and effectiveness of the TIVUS™ System when used for renal artery denervation. The study will assess the acute and chronic safety of the procedure as well as the reduction in 24-hour ambulatory mean systolic blood pressure from baseline to 3 months after the procedure.
Epistemonikos ID: dbf1c6b4d057ab8575a4563e2d0813502b53ef48
First added on: May 13, 2024